FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3844111000001108: Erythromycin 4% / Tretinoin 0.025% solution 25 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21769101000001110 Erythromycin 4% / Tretinoin 0.025% solution 25 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60127001000001118 Tretinoin 0.025% / Erythromycin 4% solution 25 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Is pack of Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution false Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Has active ingredient Tretinoin false Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Has manufactured dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Has VMP Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution true Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Has specific active ingredient Erythromycin true Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Has specific active ingredient Tretinoin true Inferred relationship Existential restriction modifier
Erythromycin 4% / Tretinoin 0.025% solution 25 ml Has dispensed dose form Basic dose form with liquid state of matter true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Aknemycin Plus solution (Crookes Healthcare Ltd) 25 ml Is a True Erythromycin 4% / Tretinoin 0.025% solution 25 ml Inferred relationship Existential restriction modifier
Aknemycin Plus solution (Lexon (UK) Ltd) 25 ml Is a True Erythromycin 4% / Tretinoin 0.025% solution 25 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start